PROTOCOL,PUB_ID,RX_CODE,RX_LABEL,AGE,SEX,RACE,HISPANIC,DISC_FL,DISC_RSN,DISC_RSN_O,EARLY_TERM_FL,TERM_RSN,TERM_AE,NUM_VAC_RECD
119,119-003,T2,D/D/D/D p55,21,Female,Other,1,No,,,No,Scheduled exit visit/end of study,2,1
119,119-005,C2,Control,30,Female,White,2,No,,,No,Scheduled exit visit/end of study,2,4
119,119-006,T2,D/D/D/D p55,25,Female,White,2,No,,,No,Scheduled exit visit/end of study,2,4
119,119-009,T2,D/D/D/D p55,36,Female,Black/African American,2,No,,,No,Scheduled exit visit/end of study,2,4
119,119-010,T2,D/D/D/D p55,37,Female,White,2,No,,,No,Scheduled exit visit/end of study,2,4
119,119-011,T1,D/D/D+D/D+D p24+p55,22,Male,White,2,No,,,No,Scheduled exit visit/end of study,2,4
119,119-013,T1,D/D/D+D/D+D p24+p55,41,Male,Black/African American,2,No,,,Yes,Unable to contact participant,2,4
119,119-018,T1,D/D/D+D/D+D p24+p55,36,Female,White,2,No,,,No,Scheduled exit visit/end of study,2,4
119,119-023,T1,D/D/D+D/D+D p24+p55,29,Female,White,2,No,,,No,Scheduled exit visit/end of study,2,3
119,119-024,T1,D/D/D+D/D+D p24+p55,46,Male,White,2,No,,,No,Scheduled exit visit/end of study,2,4
119,119-026,T1,D/D/D+D/D+D p24+p55,22,Male,White,2,No,,,No,Scheduled exit visit/end of study,2,4
119,119-028,T2,D/D/D/D p55,40,Female,Black/African American,2,No,,,No,Scheduled exit visit/end of study,2,4
119,119-032,T1,D/D/D+D/D+D p24+p55,46,Female,White,2,No,,,No,Scheduled exit visit/end of study,2,4
119,119-036,T1,D/D/D+D/D+D p24+p55,29,Female,White,2,Yes,"Clinical event other than reactogenicity, HIV infection, or death",VASOVAGAL REACTION AND SEIZURE,Yes,Unable to contact participant,2,1
119,119-041,C2,Control,23,Female,White,2,No,,,No,Scheduled exit visit/end of study,2,4
119,119-042,C1,Control,24,Female,White,1,No,,,Yes,"Participant relocated, no follow-up planned",2,4
119,119-045,T2,D/D/D/D p55,48,Female,White,2,No,,,No,Scheduled exit visit/end of study,2,4
119,119-046,T2,D/D/D/D p55,34,Male,American Indian/Alaska Native,2,Yes,"Clinical event other than reactogenicity, HIV infection, or death","Patient experienced severe gastroenteritis during the reactiongencity period, so he would like to discontinue with future study vaccinations.",Yes,Participant unable to adhere to visit schedule,2,2
119,119-048,T2,D/D/D/D p55,37,Female,Black/African American,2,No,,,No,Scheduled exit visit/end of study,2,4
119,119-052,T1,D/D/D+D/D+D p24+p55,48,Male,Black/African American,2,No,,,Yes,Unable to contact participant,2,4
119,119-055,T2,D/D/D/D p55,41,Male,Black/African American,2,No,,,No,Scheduled exit visit/end of study,2,4
119,119-059,T1,D/D/D+D/D+D p24+p55,29,Female,White,2,No,,,No,Scheduled exit visit/end of study,2,4
119,119-063,C2,Control,35,Female,White,2,Yes,Participant refused study product administration,PPT DECLINED FURTHER INJECTIONS DUE TO PAIN IN LEFT ARM WITH INJECTION,No,Scheduled exit visit/end of study,2,1
119,119-068,C1,Control,43,Female,White,2,No,,,No,Scheduled exit visit/end of study,2,3
119,119-070,T2,D/D/D/D p55,26,Female,White,2,No,,,No,Scheduled exit visit/end of study,2,4
119,119-073,T2,D/D/D/D p55,29,Female,White,2,No,,,No,Scheduled exit visit/end of study,2,4
119,119-074,T2,D/D/D/D p55,26,Female,White,2,No,,,No,Scheduled exit visit/end of study,2,4
119,119-076,T1,D/D/D+D/D+D p24+p55,50,Male,Black/African American,2,No,,,No,Scheduled exit visit/end of study,2,4
119,119-079,T1,D/D/D+D/D+D p24+p55,25,Female,Multiracial,2,Yes,Participant refused study product administration,Participant refused  d/t excessive pain,Yes,Unable to contact participant,2,1
119,119-080,T2,D/D/D/D p55,23,Male,White,2,No,,,No,Scheduled exit visit/end of study,2,4
119,119-081,T2,D/D/D/D p55,47,Male,Black/African American,2,Yes,Other,RELOCATED,Yes,"Participant relocated, no follow-up planned",2,3
119,119-082,T1,D/D/D+D/D+D p24+p55,33,Male,White,2,No,,,No,Scheduled exit visit/end of study,2,4
119,119-083,T1,D/D/D+D/D+D p24+p55,45,Male,Multiracial,2,No,,,No,Scheduled exit visit/end of study,2,4
119,119-084,T2,D/D/D/D p55,26,Female,White,2,Yes,EP device difficulty,,No,Scheduled exit visit/end of study,2,1
119,119-087,T2,D/D/D/D p55,18,Male,Asian,2,No,,,No,Scheduled exit visit/end of study,2,4
119,119-088,T2,D/D/D/D p55,37,Female,Multiracial,2,No,,,Yes,Unable to contact participant,2,4
119,119-091,T2,D/D/D/D p55,34,Male,White,1,No,,,No,Scheduled exit visit/end of study,2,4
119,119-098,T1,D/D/D+D/D+D p24+p55,22,Male,White,2,Yes,Participant refused study product administration,ppt refused,No,Scheduled exit visit/end of study,2,3
119,119-099,T2,D/D/D/D p55,25,Male,White,2,No,,,No,Scheduled exit visit/end of study,2,4
119,119-105,T1,D/D/D+D/D+D p24+p55,26,Female,White,2,No,,,No,Scheduled exit visit/end of study,2,4
119,119-108,T1,D/D/D+D/D+D p24+p55,47,Male,White,2,No,,,Yes,Unable to contact participant,2,4
119,119-109,T1,D/D/D+D/D+D p24+p55,33,Male,Other,2,No,,,No,Scheduled exit visit/end of study,2,4
119,119-110,T1,D/D/D+D/D+D p24+p55,25,Female,Native Hawaiian/Pacific Islander,2,No,,,No,Scheduled exit visit/end of study,2,4
119,119-114,T2,D/D/D/D p55,23,Female,White,2,Yes,Participant refused study product administration,ppt refused study product administration,No,Scheduled exit visit/end of study,2,3
119,119-117,T2,D/D/D/D p55,31,Female,Black/African American,2,No,,,No,Scheduled exit visit/end of study,2,4
119,119-118,T1,D/D/D+D/D+D p24+p55,20,Male,Black/African American,2,Yes,Participant refused study product administration,PPT REPORTS EXCESSIVE PAIN,Yes,Unable to contact participant,2,1
119,119-122,T1,D/D/D+D/D+D p24+p55,25,Female,White,2,No,,,No,Scheduled exit visit/end of study,2,4
119,119-127,T1,D/D/D+D/D+D p24+p55,28,Female,White,2,No,,,No,Scheduled exit visit/end of study,2,4
119,119-129,T2,D/D/D/D p55,29,Female,Asian,2,No,,,No,Scheduled exit visit/end of study,2,4
119,119-133,T2,D/D/D/D p55,35,Male,Other,2,No,,,No,Scheduled exit visit/end of study,2,4
119,119-135,T1,D/D/D+D/D+D p24+p55,22,Female,White,2,No,,,No,Scheduled exit visit/end of study,2,4
119,119-138,T1,D/D/D+D/D+D p24+p55,22,Female,White,2,No,,,No,Scheduled exit visit/end of study,2,4
119,119-143,T2,D/D/D/D p55,28,Male,Other,1,No,,,No,Scheduled exit visit/end of study,2,4
119,119-145,T1,D/D/D+D/D+D p24+p55,49,Male,Other,1,Yes,Investigator reason,Due to participant's alcohol use and not communicating safety information.,Yes,Unable to contact participant,2,3
119,119-149,T2,D/D/D/D p55,43,Male,Multiracial,2,No,,,No,Scheduled exit visit/end of study,2,4
119,119-150,C1,Control,21,Female,White,2,No,,,No,Scheduled exit visit/end of study,2,2